| Stage | KRMD | % of rev | OPXS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $12M | 100.00% | $10M | 100.00% | KRMD ×1.24 |
| Gross profit | $8M | 65.14% | $3M | 34.18% | KRMD +31.0pp |
| Operating income | $626,991 | 5.21% | $1M | 14.30% | OPXS +9.1pp |
| Pre-tax income | $258,249 | 2.14% | $1M | 14.59% | OPXS +12.4pp |
| Net income | $252,449 | 2.10% | $1M | 13.16% | OPXS +11.1pp |
| Stage | KRMD | OPXS | Gap · A − B |
|---|---|---|---|
| Revenue | $12M100.00% | $10M100.00% | KRMD ×1.24 |
| Gross profit | 65.14%$8M | 34.18%$3M | KRMD +31.0pp |
| Operating income | 5.21%$626,991 | 14.30%$1M | OPXS +9.1pp |
| Pre-tax income | 2.14%$258,249 | 14.59%$1M | OPXS +12.4pp |
| Net income |
| 2.10%$252,449 |
| 13.16%$1M |
| OPXS +11.1pp |
No disclosed counterparties: KRMD, OPXS.